C

Compass Pathways

Develops psilocybin-based therapies for TRD

Executive Director, Compensation

Compensation & BenefitsPosted on Nov 10
Full-timeRemote in USA

About the Job

Requirements

  • A bachelor's degree in Human Resources, Business, Finance, Economics, or a related discipline is required.
  • Significant progressive compensation experience, including substantial expertise in executive compensation strategy, program design, and governance.
  • Demonstrated experience advising CEOs, executive leadership teams, Boards of Directors, and Compensation Committees on executive pay strategy, reviews, and governance.
  • Expertise in equity compensation, including stock options, restricted stock units, and performance-based long-term incentive programs.
  • Experience in executive benchmarking, annual incentive design, compensation modeling, and pay governance.
  • Deep understanding of compensation market practices, regulatory requirements, tax considerations, and compensation accounting principles.
  • Advanced analytical and financial modeling skills, including the ability to assess incentive outcomes, equity implications, and pay positioning.
  • Ability to translate complex compensation matters into clear recommendations for senior leaders and Board members.
  • Strong influencing, negotiation, and stakeholder-management capabilities, with credibility to operate at executive and Board level.
  • Ability to balance talent priorities, financial considerations, and shareholder interests while exercising discretion, sound judgment, and integrity in handling confidential compensation matters.
  • Applicants must have employment rights in the country to which they are applying; employment visa sponsorship is unavailable.

Responsibilities

  • Develop and lead the company’s executive compensation strategy, including base salary, annual and long-term incentives, equity awards, and retention arrangements, aligning them with business objectives, shareholder interests, and long-term value creation.
  • Advise the Chief People Officer, CEO, and executive leadership team on executive pay, incentive design, compensation governance, and emerging market practices.
  • Partner with the Chief People Officer, CEO, Legal, and external advisers to prepare recommendations and materials for the Board of Directors and Compensation Committee.
  • Oversee executive compensation benchmarking, annual reviews, pay recommendations, and incentive outcomes.
  • Lead the company’s equity compensation strategy, including stock option and restricted stock unit awards, equity dilution, and share usage.
  • Oversee executive compensation disclosures and proxy statement preparation in partnership with Legal and external advisers.
  • Establish and evolve the company’s broader compensation philosophy, salary structures, job architecture, and market-benchmarking frameworks.
  • Oversee annual compensation planning, including merit increases, promotions, market adjustments, and pay equity assessments.
  • Partner with Finance on compensation budgeting, forecasting, financial modeling, and the financial impact of compensation programs.
  • Monitor market, regulatory, governance, and investor developments to ensure compensation programs remain compliant, competitive, and aligned with shareholder expectations.
  • Provide clear, data-driven compensation insights and recommendations to senior leaders using market data, analytics, and industry trends.

Desired Qualifications

  • An MBA or relevant master’s degree is preferred.
  • Experience supporting a US commercial-stage organization, ideally in biotechnology, pharmaceuticals, or the broader life sciences industry, is strongly preferred.
  • Experience within a publicly traded company is highly desirable, including knowledge of SEC reporting, proxy statement requirements, and executive compensation disclosure.

About the Company

Compass Pathways

Develops psilocybin-based therapies for TRD

COMPASS Pathways develops psilocybin-based therapies for mental health, focusing on treating treatment-resistant depression (TRD). Its lead drug candidate, COMP360, is a high-purity psilocybin formulation given alongside psychological support from trained therapists. The treatment is delivered through a global Phase 3 program, aiming to establish a regulatory-approved therapy. Compared with other players, COMPASS emphasizes a standardized therapeutic model that pairs a pharmaceutical compound with guided psychotherapy and has the largest psilocybin Phase 3 program to date, supported by Breakthrough Therapy designation from the FDA. The company originated from a nonprofit idea, transformed into a for-profit entity to fund extensive trials, and is pursuing regulatory approval and eventual commercialization through licensing and partnerships. Its goal is to bring approved, evidence-based psilocybin treatments to patients with TRD and scale access through a commercial pathway.

Company size
201-500
Company stage
IPO
Headquarters
London, United Kingdom
Founded
2016

Recently Posted Jobs

Explore more opportunities at Compass Pathways

See more jobs